Nephros, Inc. (NASDAQ:NEPH) Sees Large Drop in Short Interest

Nephros, Inc. (NASDAQ:NEPH) was the recipient of a significant decline in short interest in April. As of April 15th, there was short interest totalling 11,400 shares, a decline of 45.7% from the March 31st total of 21,000 shares. Based on an average daily volume of 14,000 shares, the days-to-cover ratio is presently 0.8 days. Currently, 0.1% of the company’s stock are sold short.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Nephros stock. Topline Capital Management LLC purchased a new position in shares of Nephros, Inc. (NASDAQ:NEPH) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 419,887 shares of the company’s stock, valued at approximately $617,000. Topline Capital Management LLC owned approximately 3.98% of Nephros as of its most recent filing with the SEC. 41.10% of the stock is owned by institutional investors.

Nephros Price Performance

Shares of NASDAQ NEPH opened at $1.95 on Tuesday. The business’s 50-day moving average price is $1.73 and its two-hundred day moving average price is $1.60. Nephros has a one year low of $1.36 and a one year high of $2.55. The company has a market capitalization of $20.67 million, a P/E ratio of -21.67 and a beta of 1.05.

Nephros (NASDAQ:NEPH) last issued its earnings results on Monday, March 24th. The company reported $0.03 EPS for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.04. Nephros had a negative return on equity of 11.39% and a negative net margin of 6.86%. The firm had revenue of $3.87 million for the quarter, compared to the consensus estimate of $3.67 million.

About Nephros

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.